Literature DB >> 28148799

Computational Prediction of the Heterodimeric and Higher-Order Structure of gpE1/gpE2 Envelope Glycoproteins Encoded by Hepatitis C Virus.

Holly Freedman1, Michael R Logan2, Darren Hockman2, Julia Koehler Leman3,4, John Lok Man Law2, Michael Houghton1.   

Abstract

Despite the recent success of newly developed direct-acting antivirals against hepatitis C, the disease continues to be a global health threat due to the lack of diagnosis of most carriers and the high cost of treatment. The heterodimer formed by glycoproteins E1 and E2 within the hepatitis C virus (HCV) lipid envelope is a potential vaccine candidate and antiviral target. While the structure of E1/E2 has not yet been resolved, partial crystal structures of the E1 and E2 ectodomains have been determined. The unresolved parts of the structure are within the realm of what can be modeled with current computational modeling tools. Furthermore, a variety of additional experimental data is available to support computational predictions of E1/E2 structure, such as data from antibody binding studies, cryo-electron microscopy (cryo-EM), mutational analyses, peptide binding analysis, linker-scanning mutagenesis, and nuclear magnetic resonance (NMR) studies. In accordance with these rich experimental data, we have built an in silico model of the full-length E1/E2 heterodimer. Our model supports that E1/E2 assembles into a trimer, which was previously suggested from a study by Falson and coworkers (P. Falson, B. Bartosch, K. Alsaleh, B. A. Tews, A. Loquet, Y. Ciczora, L. Riva, C. Montigny, C. Montpellier, G. Duverlie, E. I. Pecheur, M. le Maire, F. L. Cosset, J. Dubuisson, and F. Penin, J. Virol. 89:10333-10346, 2015, https://doi.org/10.1128/JVI.00991-15). Size exclusion chromatography and Western blotting data obtained by using purified recombinant E1/E2 support our hypothesis. Our model suggests that during virus assembly, the trimer of E1/E2 may be further assembled into a pentamer, with 12 pentamers comprising a single HCV virion. We anticipate that this new model will provide a useful framework for HCV envelope structure and the development of antiviral strategies.IMPORTANCE One hundred fifty million people have been estimated to be infected with hepatitis C virus, and many more are at risk for infection. A better understanding of the structure of the HCV envelope, which is responsible for attachment and fusion, could aid in the development of a vaccine and/or new treatments for this disease. We draw upon computational techniques to predict a full-length model of the E1/E2 heterodimer based on the partial crystal structures of the envelope glycoproteins E1 and E2. E1/E2 has been widely studied experimentally, and this provides valuable data, which has assisted us in our modeling. Our proposed structure is used to suggest the organization of the HCV envelope. We also present new experimental data from size exclusion chromatography that support our computational prediction of a trimeric oligomeric state of E1/E2.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  E1/E2 heterodimer; Martini force field; Rosetta program; computational structural biology; hepatitis C virus

Mesh:

Substances:

Year:  2017        PMID: 28148799      PMCID: PMC5375693          DOI: 10.1128/JVI.02309-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  99 in total

1.  Multipass membrane protein structure prediction using Rosetta.

Authors:  Vladimir Yarov-Yarovoy; Jack Schonbrun; David Baker
Journal:  Proteins       Date:  2006-03-01

2.  Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.

Authors:  Budhaditya Mazumdar; Arup Banerjee; Keith Meyer; Ranjit Ray
Journal:  Hepatology       Date:  2011-07-25       Impact factor: 17.425

3.  Delineation of regions important for heteromeric association of hepatitis C virus E1 and E2.

Authors:  M Yi; Y Nakamoto; S Kaneko; T Yamashita; S Murakami
Journal:  Virology       Date:  1997-04-28       Impact factor: 3.616

4.  Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.

Authors:  R Thomssen; S Bonk; A Thiele
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

5.  Recombinant hepatitis C virus envelope glycoprotein vaccine elicits antibodies targeting multiple epitopes on the envelope glycoproteins associated with broad cross-neutralization.

Authors:  Jason Alexander Ji-Xhin Wong; Rakesh Bhat; Darren Hockman; Michael Logan; Chao Chen; Aviad Levin; Sharon E Frey; Robert B Belshe; D Lorne Tyrrell; John Lok Man Law; Michael Houghton
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

6.  Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry.

Authors:  Heidi E Drummer; Pantelis Poumbourios
Journal:  J Biol Chem       Date:  2004-05-10       Impact factor: 5.157

7.  Structural characterization of the transmembrane proximal region of the hepatitis C virus E1 glycoprotein.

Authors:  Roberta Spadaccini; Gerardino D'Errico; Viviana D'Alessio; Eugenio Notomista; Alessia Bianchi; Marcello Merola; Delia Picone
Journal:  Biochim Biophys Acta       Date:  2009-11-03

8.  Structure-function analysis of hepatitis C virus envelope glycoproteins E1 and E2.

Authors:  Aparajita Nayak; Nagarajan Pattabiraman; Numrah Fadra; Radoslav Goldman; Sergei L Kosakovsky Pond; Raja Mazumder
Journal:  J Biomol Struct Dyn       Date:  2014-10-15

9.  Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.

Authors:  Zhen-yong Keck; Jinming Xia; Yong Wang; Wenyan Wang; Thomas Krey; Jannick Prentoe; Thomas Carlsen; Angela Ying-Jian Li; Arvind H Patel; Stanley M Lemon; Jens Bukh; Felix A Rey; Steven K H Foung
Journal:  PLoS Pathog       Date:  2012-04-12       Impact factor: 6.823

Review 10.  Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies.

Authors:  Giuseppe Sautto; Alexander W Tarr; Nicasio Mancini; Massimo Clementi
Journal:  Clin Dev Immunol       Date:  2013-07-09
View more
  16 in total

1.  Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain.

Authors:  Rehab I Moustafa; Juliano G Haddad; Lydia Linna; Xavier Hanoulle; Véronique Descamps; Ahmed Atef Mesalam; Thomas F Baumert; Gilles Duverlie; Philip Meuleman; Jean Dubuisson; Muriel Lavie
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

2.  Chlorcyclizine Inhibits Viral Fusion of Hepatitis C Virus Entry by Directly Targeting HCV Envelope Glycoprotein 1.

Authors:  Zongyi Hu; Adam Rolt; Xin Hu; Christopher D Ma; Derek J Le; Seung Bum Park; Michael Houghton; Noel Southall; D Eric Anderson; Daniel C Talley; John R Lloyd; Juan C Marugan; T Jake Liang
Journal:  Cell Chem Biol       Date:  2020-05-07       Impact factor: 8.116

Review 3.  Designing an HCV vaccine: a unique convergence of prevention and therapy?

Authors:  Christopher M Walker
Journal:  Curr Opin Virol       Date:  2017-05-25       Impact factor: 7.090

4.  Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening.

Authors:  Jennifer M Pfaff-Kilgore; Edgar Davidson; Kathryn Kadash-Edmondson; Mayda Hernandez; Erin Rosenberg; Ross Chambers; Matteo Castelli; Nicola Clementi; Nicasio Mancini; Justin R Bailey; James E Crowe; Mansun Law; Benjamin J Doranz
Journal:  Cell Rep       Date:  2022-05-24       Impact factor: 9.995

5.  A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanism.

Authors:  Florian Douam; Floriane Fusil; Margot Enguehard; Linda Dib; Francesca Nadalin; Loïc Schwaller; Gabriela Hrebikova; Jimmy Mancip; Laurent Mailly; Roland Montserret; Qiang Ding; Carine Maisse; Emilie Carlot; Ke Xu; Els Verhoeyen; Thomas F Baumert; Alexander Ploss; Alessandra Carbone; François-Loïc Cosset; Dimitri Lavillette
Journal:  PLoS Pathog       Date:  2018-03-05       Impact factor: 6.823

Review 6.  Role of Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.

Authors:  Yimin Tong; Dimitri Lavillette; Qingchao Li; Jin Zhong
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

Review 7.  Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development.

Authors:  Eric A Toth; Andrezza Chagas; Brian G Pierce; Thomas R Fuerst
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

Review 8.  Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus.

Authors:  Thomas R Fuerst; Brian G Pierce; Zhen-Yong Keck; Steven K H Foung
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

9.  Recombinant Flag-tagged E1E2 glycoproteins from three hepatitis C virus genotypes are biologically functional and elicit cross-reactive neutralizing antibodies in mice.

Authors:  Vasil B Krapchev; Malgorzata Rychłowska; Alicja Chmielewska; Karolina Zimmer; Arvind H Patel; Krystyna Bieńkowska-Szewczyk
Journal:  Virology       Date:  2018-04-06       Impact factor: 3.616

Review 10.  Computational Modeling of Hepatitis C Virus Envelope Glycoprotein Structure and Recognition.

Authors:  Johnathan D Guest; Brian G Pierce
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.